Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03110029 · ClinicalTrials.gov registry record · Phase 4
Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT03110029 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 13 participants.
The verdict
NCT03110029, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study will test how well efinaconazole solution (Jublia) works to treat toenail fungal infections in patients who wear polish compared to those who do not.
Interventions
- DRUG Efinaconazole 10% Topical Application Solution [JUBLIA]
- OTHER Application of Nail Polish
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-09 |
| Est. Completion | 2018-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03110029
The ClinicalTrials.gov registry entry for NCT03110029 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Efinaconazole 10% Topical Application Solution [JUBLIA] is the first listed.
NCT03110029 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03110029 about?
NCT03110029 is a clinical study titled "Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish". This study will test how well efinaconazole solution (Jublia) works to treat toenail fungal infections in patients who wear polish compared to those who do not.
What is the current status of trial NCT03110029?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2015-09. Estimated completion is 2018-07.
What interventions are being tested in trial NCT03110029?
The interventions under investigation include: Efinaconazole 10% Topical Application Solution [JUBLIA] (DRUG), Application of Nail Polish (OTHER).
Who is sponsoring clinical trial NCT03110029?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.